Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Improvement in Lung Clearance Index and Chest Computed Tomography Scores with Elexacaftor/Tezacaftor/Ivacaftor Treatment in People with Cystic Fibrosis Aged 12 Years and Older - The RECOVER Trial.
McNally P, Lester K, Stone G, Elnazir B, Williamson M, Cox D, Linnane B, Kirwan L, Rea D, O'Regan P, Semple T, Saunders C, Tiddens HAWM, McKone E, Davies JC; RECOVER Study Group. McNally P, et al. Among authors: elnazir b. Am J Respir Crit Care Med. 2023 Nov 1;208(9):917-929. doi: 10.1164/rccm.202308-1317OC. Am J Respir Crit Care Med. 2023. PMID: 37703083 Clinical Trial.
Reduction in abdominal symptoms (CFAbd-Score), faecal M2-pyruvate-kinase and Calprotectin over one year of treatment with Elexacaftor-Tezacaftor-Ivacaftor in people with CF aged ≥12 years - The RECOVER study.
Mainz JG, Lester K, Elnazir B, Williamson M, McKone E, Cox D, Linnane B, Zagoya C, Duckstein F, Barucha A, Davies JC, McNally P; RECOVER Study Group. Mainz JG, et al. Among authors: elnazir b. J Cyst Fibros. 2023 Oct 7:S1569-1993(23)00922-0. doi: 10.1016/j.jcf.2023.10.001. Online ahead of print. J Cyst Fibros. 2023. PMID: 37806792
The clinical impact of Lumacaftor-Ivacaftor on structural lung disease and lung function in children aged 6-11 with cystic fibrosis in a real-world setting.
McNally P, Linnane B, Williamson M, Elnazir B, Short C, Saunders C, Kirwan L, David R, Kemner-Van de Corput MPC, Tiddens HAWM, Davies JC, Cox DW. McNally P, et al. Among authors: elnazir b. Respir Res. 2023 Aug 11;24(1):199. doi: 10.1186/s12931-023-02497-0. Respir Res. 2023. PMID: 37568199 Free PMC article.
Diffuse alveolar haemorrhage in children: an international multicentre study.
Ring AM, Schwerk N, Kiper N, Aslan AT, Aurora P, Ayats R, Azevedo I, Bandeira T, Carlens J, Castillo-Corullon S, Cobanoglu N, Elnazir B, Emiralioğlu N, Eyuboglu TS, Fayon M, Gursoy TR, Hogg C, Kötz K, Karadag B, Látalová V, Krenke K, Lange J, Manali ED, Osona B, Papiris S, Proesmann M, Reix P, Roditis L, Rubak S, Rumman N, Snijders D, Stehling F, Weiss L, Yalcın E, Zirek F, Bush A, Clement A, Griese M, Buchvald FF, Nathan N, Nielsen KG. Ring AM, et al. Among authors: elnazir b. ERJ Open Res. 2023 Apr 24;9(2):00733-2022. doi: 10.1183/23120541.00733-2022. eCollection 2023 Mar. ERJ Open Res. 2023. PMID: 37101741 Free PMC article.
Global Pediatric Pulmonology Alliance (GPPA) proposal for COVID-19 vaccination in children.
Rodewald LE, Shen KL, Yang YH, Wong GW, Namazova-Baranova L, Rosenwasser LJ, Alharbi AS, Chang AB, Buttery J, Elnazir B, Etzel RA, Goh A, Hoey H, Horne R, Kerem E, Muraro A, O'Callaghan C, Ouchi K, Singh V, Wang JY, Li S, Guan Y; Global Pediatric Pulmonology Alliance (GPPA) Council; Zheng YJ, Xie Z, Lu G, Jiang Y, Li XW, Jiang RM, Wang XC, Deng JK, Lu XX, Xu BP, Wei Z, Feng LZ, Zhao ZY; Global Pediatric Pulmonology Alliance (GPPA) Expert Panel on Infectious Diseases and COVID-19. Rodewald LE, et al. Among authors: elnazir b. World J Pediatr. 2021 Oct;17(5):458-461. doi: 10.1007/s12519-021-00459-4. World J Pediatr. 2021. PMID: 34586608 Free PMC article. No abstract available.
48 results